PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
05-May-2021 Kuros Biosciences strengthens its patent position on use of Fibrin-PTH in spinal fusion Kuros Biosciences AG
04-May-2021 HAEMATO AG proposes dividend payment HAEMATO AG
04-May-2021 Scipher Applies Spectra™ Platform to Discover Drugs Targeting Autoimmune Patients Refractory to Existing Therapies B3C newswire
04-May-2021 Evotec SE to announce results for the first quarter 2021 on 11 May 2021 Evotec SE
04-May-2021 Annual General Meeting of April 30, 2021 Sanofi
04-May-2021 Moberg Pharma’s Interim report for January – March 2021 to be published on May 11 - Invitation to teleconference Moberg Pharma
04-May-2021 Newron announces Paragraph IV ANDA filing for Xadago® (safinamide) in the USA Newron Pharmaceuticals S.p.A.
04-May-2021 HUTCHMED Completes Rolling Submission of NDA to U.S. FDA for Surufatinib for the Treatment of Advanced Neuroendocrine Tumors HUTCHMED
04-May-2021 Verona Pharma to Present Expanded Analysis of Phase 2b COPD Data with Ensifentrine at the American Thoracic Society 2021 International Conference Verona Pharma
04-May-2021 Enesi Pharma Achieves Preclinical Proof-of-Concept with ImplaVax®-Enabled Pandemic Influenza Vaccine Enesi Pharma
04-May-2021 ISA Pharmaceuticals Co-authors Publication in Nature Reviews Cancer on Therapeutic Cancer Vaccines ISA Pharmaceuticals
04-May-2021 Cumulus Neuroscience Announces £6 million Funding Round Led by the Dementia Discovery Fund and joined by LifeArc and UK Future Fund Cumulus Neuroscience
04-May-2021 Evotec and the GCKD study enter into strategic collaboration to build a unique molecular patient database Evotec SE
04-May-2021 N-SIDE Production App launched to optimize manufacturing for clinical development and deliver millions in savings Sciad Newswire
04-May-2021 Newron announces Paragraph IV ANDA filing  for Xadago® (safinamide) in the USA Newron Pharmaceuticals SpA
04-May-2021 COLTENE Holding AG: Change in the Group Management COLTENE Holding AG
04-May-2021 Relief and Applied Pharma Research (APR) Sign Binding Term Sheet for Relief to Acquire All Outstanding Shares of APR RELIEF THERAPEUTICS Holdings AG
04-May-2021 Newron announces Paragraph IV ANDA filing for Xadago(R) (safinamide) in the USA Newron Pharmaceuticals S.p.A.
04-May-2021 Pharmaceutical Intermediate Market projected to reach US$ 37,290.33 million by 2028 | Codexis, chiracon, Vertellus Holdings, Lianhe Chemical Technology, theinsightpartners
04-May-2021 Medical Cannabis Market Hits US$ 49,116.4 million by 2028 and to grow at a CAGR of 23.9% - Aphria, Aurora Cannabis, VIVO Cannabis, Tilray, CANVORY theinsightpartners